Polymerase News and Research

RSS
New bioinformatics method for viral sgRNA analysis

New bioinformatics method for viral sgRNA analysis

Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

Study suggests efficacy of SARS-CoV-2 main protease inhibitors is not compromised in current COVID-19 variants

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

SARS-CoV-2 transmission across age groups makes age-based interventions ineffective

SARS-CoV-2 transmission across age groups makes age-based interventions ineffective

Plant-derived virus-like particle vaccines against SARS-CoV-2

Plant-derived virus-like particle vaccines against SARS-CoV-2

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Natural COVID-19 infection offers protection from gamma and delta variants of SARS-CoV-2

Study shows that nucleic acid amplification tests more accurate in detecting SARS-CoV-2 than rapid antigen

Study shows that nucleic acid amplification tests more accurate in detecting SARS-CoV-2 than rapid antigen

Prior infection with SARS-CoV-2 continues to provide protection from reinfection

Prior infection with SARS-CoV-2 continues to provide protection from reinfection

Host and in vitro genomic variability of SARS-CoV-2 and its variants

Host and in vitro genomic variability of SARS-CoV-2 and its variants

Increased illness burden of COVID-19 among unvaccinated first responders

Increased illness burden of COVID-19 among unvaccinated first responders

Error rate of bacterial DNA polymerase is consistently higher under microgravity, study shows

Error rate of bacterial DNA polymerase is consistently higher under microgravity, study shows

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

COVID vaccines effectively reduce outbreaks of SARS-CoV-2 alpha and delta viruses in households

COVID vaccines effectively reduce outbreaks of SARS-CoV-2 alpha and delta viruses in households

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

An analysis of SARS-CoV-2 breakthrough infections by variant and vaccine

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

Study finds no evidence to support favipiravir use in mild or asymptomatic COVID-19 patients

How often does SARS-CoV-2 infect alongside another viruses?

How often does SARS-CoV-2 infect alongside another viruses?

The introduction and rapid spread of SARS-CoV-2 Gamma in Venezuela

The introduction and rapid spread of SARS-CoV-2 Gamma in Venezuela

Prediction of severe infection based on SARS-CoV-2 genomic analysis

Prediction of severe infection based on SARS-CoV-2 genomic analysis

Antiviral activity of a photoactivable natural product on coronaviruses

Antiviral activity of a photoactivable natural product on coronaviruses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.